Investigators concluded, “Cannabis use does not appear to be related to lung function even after years of use.”
“People may be obtaining codeine from pharmacies for misuse; recreational cannabis laws reduce this illicit demand.”
“Subgroups with past-year cannabis use that displayed significant declines in DUIC include males, [those] ages 18–25, … and those living in a state with a medical cannabis law.”
The proposed rules are now subject to a public comment period, which runs until March 18, 2023.
Over 90 percent of subjects treated with the combination therapy experienced a ≥50 percent reduction in seizure frequency at six-months.
Six of the seven participants reported “an improvement in symptoms” and “none of the participants reported any adverse side effects.”
“The findings of this study indicate that neither past nor current cannabis use are associated with the likelihood of having clinical hypertension,” investigators concluded.
One-in-four respondents reported reducing their need for medical interventions since using cannabis, and nearly one-third acknowledged reducing their use of prescription medications.